Skip to main content
Equibles

KINGDON CAPITAL MANAGEMENT, L.L.C.

Position in JSPR — Jasper Therapeutics, Inc.

CIK 1000097 NEW YORK, NY
Back to JSPR Full portfolio

Position in JSPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$569,236
-$615,208 QoQ
Shares Held
1,352,106
0.0% QoQ
Ownership
4.06%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#3
of 44 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JSPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

KINGDON CAPITAL MANAGEMENT, L.L.C. holds $112,338,858 across 9 Biotechnology names. JSPR ranks #9 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SNDX
Syndax Pharmaceuticals Inc
 2,500,000 $54,650,000
2 OLMA
Olema Pharmaceuticals, Inc.
 1,200,000 $15,012,000
3 CYTK
Cytokinetics Inc
 157,100 $13,383,349
4 ZVRA
Zevra Therapeutics, Inc.
 775,000 $11,113,500
5 ALDX
Aldeyra Therapeutics, Inc.
 2,652,315 $5,649,430
6 IVA
Inventiva S.A.
 1,270,000 $4,800,600
7 ELDN
Eledon Pharmaceuticals, Inc.
 1,039,275 $4,094,743
8 CMPX
Compass Therapeutics, Inc.
 1,400,000 $3,066,000

All Filings in JSPR

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $569,236 1,352,106
2026-03-31 $1,184,444 1,352,106
2025-09-30 $3,153,131 1,324,845
2025-06-30 $3,800,123 684,707
2025-03-31 $2,107,000 490,000
2024-12-31 $9,556,860 447,000
2024-09-30 $9,348,570 497,000
2024-06-30 $11,281,900 497,000
2024-03-31 $14,591,920 497,000
2023-12-31 $2,793,060 3,540,000
2023-09-30 $2,128,000 3,040,000
2023-06-30 $4,164,800 3,040,000
2023-03-31 $5,502,400 3,040,000
2022-12-31 $260,820 540,000
2022-09-30 $426,060 540,000
2022-06-30 $1,042,200 540,000
2022-03-31 $1,917,000 540,000
2021-12-31 $4,239,000 540,000